Bioluminescence screening in vitro (bio-siv) assays for high-volume antimycobacterial drug discovery

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 6, 1996, Pages 1536-1541

  Arain, Taraq M ^a   Resconi, Anna E ^a   Hickey, Mark J ^a   Stover, C Kendall ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BIOLUMINESCENCE; MASS SCREENING; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TUBERCULOSIS;

EID: 0029938667     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.6.1536     Document Type: Article

References (24)

1. Arain, T. M., A. E. Resconi, D. C. Singh, and C. K. Stover. 1996. Reporter gene technology to assess activity of antimycobacterial agents in macrophages Antimicrob. Agents Chemother. 40:1540-1542.
2. Bates, J. H., and J. L. McClellan. 1995. Tuberculosis chemotherapy. The need for new antituberculosis drugs is urgent. Am. J. Respir. Crit. Care Med 151:942-943
3. Beaty, P. S., J. Ahnell, L. Robinson, and M. Deal. 1994. Detection of Mycobacterium tuberculosis using a fluorescence quenching-based oxygen sensor, abstr. C-11, p. 510. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology. Washington, D.C.
4. Beckers, B., H. R. M. Lang, D. Schimke, and A. Lammers. 1985. Evaluation of a bioluminescence assay for rapid antimicrobial susceptibility testing of mycobacteria Eur J. Clin. Microbiol 4:556-561.
5. Conville, P. S., F. G. Witebsky, and J. D. MacLowry. 1994. Antimicrobial susceptibilities of mycobacteria as determined by differential light scattering and correlation with results from multiple reference laboratories. J. Clin. Microbiol. 32:1554-1559.
6. Cooksey, R. C., J. T. Crawford, W. R. Jacobs, Jr., and T. M. Shinnick. 1993. A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob. Agents Chemother 37:1348-1352.
7. Cooksey, R. C., G. P. Morlock, M. Beggs, and J. T. Crawford. 1995. Bioluminescence method to evaluate antimicrobial agents against Mycobacterium avium Antimicrob. Agents Chemother. 39:754-756.
8. Dolin, P. J., M. C. Raviglione, and A. Kochi. 1994. Global tuberculosis incidence and mortality during 1990-2000. Bull. W. H. O. 72:213-220.
9. Hickey, M. J., T. M. Arain, R. M. Shawar, D. J. Humble, M. H. Langhorne, J. N. Morgenroth, and C. K. Stover. 1996. Luciferase in vivo expression technology, use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob. Agents Chemother. 40:400-407.
10. Hinman, A. R., and J. M. Hughes. 1992. National plan to combat multidrug-resistant tuberculosis. Morbid. Mortal. Weekly Rep. 41:1-48.
11. Inderlied, C. B., C. A. Kemper, and L. E. Bermudez. 1993. The Mycobacterium avium complex Clin Microbiol. Rev. 6:266-310.
12. Jacobs, W. R., Jr., R. G. Barletta, R. Udani, J. Chan, G. Kalkut, G. Sosne, T. Kieser, G. J. Sarkis, G. F. Hatfull, and B. R. Bloom. 1993 Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260:819-822.
13. Jacobs, W. R., Jr., G. V. Kalpana, J. D. Cirillo, L. Pascopella, S. B. Snapper, R. A. Udani, W. Jones, and R. G. Barletta. 1991 Genetic systems for mycobacteria. Methods Enzymol. 204:537-555
14. Kodsi, S. E., S. B. Walters, D. T. Stitt, and B. A. Hanna. 1994. Rapid detection of MDRTB from culture using a novel susceptibility system, abstr. C-114, p. 510 In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
15. Mahairas, G. G., P. J. Sabo, M. J. Hickey, D. C. Singh, and C. K. Stover. 1996 Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178:1274-1282.
16. National Committee for Clinical Laboratory Standards. 1990. Antimycobacterial susceptibility testing; proposed standards. Publication M24-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. Nilsson, L. E., S. E. Hoffner, and S. Ansehn. 1988 Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrob Agents Chemother. 32:1208-1212.
18. Raviglione, M. C., D. E. Snider, and A. Kochi. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273: 220-226.
19. Sarkis, G. J., W. R. Jacobs, Jr., and G. F. Hatfull. 1995. L5 luciferase reporter mycobacteriophages: a sensitive tool for the detection and assay of live mycobacteria. Mol Microbiol. 15:1055-1067.
20. Sarmientos, P., J. E. Sylvester, S. Contente, and M. Cashel. 1983. Differential stringent control of the tandem E coli ribosomal RNA promoters from the rrnA operon expressed in vivo in multicopy plasmids. Cell 32:1337-1346.
21. Siddiqi, S. H., L. B. Heifets, M. H. Cynamon, N. M. Hooper, A. Laszlo, J. P. Libonati, P. J. Lindholm-Levy, and N. Pearson. 1993. Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates J. Clin. Microbiol. 31:2332-2338
22. Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennett, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, S. B. Snapper, R. G. Barletta, W. R. Jacobs, and B. R. Bloom. 1991 New use of BCG for recombinant vaccines. Nature 351:456-460
23. Tomioka, H., and H. Saito. 1991. In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs Kekkaku 66:489-492.
24. Yamori, S., and M. Tsukamura. 1991. Paradoxical effect of Tween 80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfamethoxine in the Mycobacterium avium-Mycobacterium intracellulare complex. Microbiol. Immunol 35:921-926.